Lejeune, F. http://orcid.org/0000-0002-9984-4160
Chatton, A.
Laplaud, D.-A.
Le Page, E.
Wiertlewski, S.
Edan, G.
Kerbrat, A.
Veillard, D.
Hamonic, S.
Jousset, N.
Le Frère, F.
Ouallet, J.-C.
Brochet, B.
Ruet, A.
Foucher, Y.
Michel, Laure
Article History
Received: 22 April 2020
Revised: 21 July 2020
Accepted: 10 August 2020
First Online: 9 September 2020
Compliance with ethical standards
:
: F. Lejeune reports no disclosures. A. Chatton reports no disclosures. D.-A. Laplaud reports personal fees and non-financial support from Biogen, Merck, Novartis, Genzyme, Teva, Roche and MedDay, all outside the submitted work. S. Wiertlewski received consultancy fees, speaker fees, honoraria and clinical research grants from Biogen-Idec, Merck, Novartis, Genzyme, Roche, Sanofi-Aventis and Teva, all outside the submitted work. G. Edan reports no disclosures. E. Le Page has received grants, personal fees and non-financial support from Biogen Idec, Genzyme, Merck-Serono, Novartis, Roche, Sanofi and Teva, all outside the submitted work. A. Kerbrat reports no disclosures. D. Veillard reports no disclosures. S. Hamonic reports no disclosures. N. Jousset reports no disclosures. F. Le Frère reports no disclosures. J.-C. Ouallet reports personal fees from Biogen, Roche and Genzyme, and grants, personal fees and non-financial support from Novartis and Merck, all outside the submitted work. B. Brochet reports grants from the French Ministry of Health, personal fees and non-financial support from Biogen-Idec, grants from Merck-Serono, personal fees and non-financial support from Novartis, personal fees and non-financial support from Genzyme, grants, personal fees and non-financial support from Teva, and grants and non-financial support from Bayer, all outside the submitted work. A. Ruet has received consultancy fees, speaker fees, research grants (non-personal) or honoraria from Medday, Novartis, Biogen Idec, Genzyme, Roche, Teva, and Merck, all outside the submitted work. Y. Foucher has received speaking honoraria from Biogen and Sanofi-Genzyme. L. Michel has received grants and fees from Biogen Idec, Merck Serono, Roche, Sanofi Genzyme, Teva and Novartis, all outside the submitted work.
: Data confidentiality and safety were ensured in accordance with the recommendations of the French National Ethics Committee (CNIL-Commission Nationale Informatique et Libertés), which provided approval for the EDMUS database. All data identifying patients were anonymised. All human studies were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Specific national laws were also observed.